Pervasis Therapeutics Inc of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2009-09-15. The offering totals $17.4M, of which $10.0M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Frederic Chereau | Director | Cambridge, MA |
| Earl M Collier | Director | Cambridge, MA |
| Elazer R Edelman | Director | Cambridge, MA |
| Robert F Higgins | Director | Cambridge, MA |
| Peter B Hutt | Director | Cambridge, MA |
| Edwin M Kania | Director | Cambridge, MA |
| Robert S Langer | Director | Newton, MA |
| Frank Litvack | Director | MENLO PARK, CA |
| AMIR NASHAT | Director | San Diego, CA |
| Yoram Richter | Director | Cambridge, MA |
| Frederic Chereau | Executive Officer | Cambridge, MA |
| Helen M Nugent | Executive Officer | Cambridge, MA |